Group 1 - The core viewpoint of the news is that Dishi Medical has successfully completed nearly 100 million yuan in Series A financing, which will be used to accelerate the registration and clinical trials of its general microsurgery robot and promote the commercialization of its ophthalmic surgery robot products [1] - Dishi Medical has completed multiple rounds of financing within a year, including Pre-A, Pre-A+, and Pre-A++ rounds, indicating strong investor interest and confidence in the company's growth potential [1] - The company was founded in July 2021 by a team from top institutions and has applied for and authorized dozens of patents in China and the United States, showcasing its commitment to innovation and technology [1] Group 2 - Dishi Medical's ophthalmic surgery robot has completed the first registered clinical trials in several leading hospitals in China and has entered the "green channel" for innovative medical device review, making it the first ophthalmic surgery robot to do so in the country [2] - The general microsurgery robot developed by Dishi Medical successfully completed the world's first robot-assisted lymphatic-venous anastomosis surgery for Alzheimer's treatment, demonstrating its advanced capabilities in microsurgery [2] - The robot can achieve a precision level of 0.1mm in lymphatic and venous anastomosis, significantly improving the safety and accuracy of surgeries compared to traditional methods [2] Group 3 - The founder of Dishi Medical emphasized the rigid demand and clear advantages of microsurgery robots in enhancing stability, precision, and freedom in surgical operations, as well as alleviating surgeon fatigue during long procedures [3] - The company aims to expand the application of robotic microsurgery technology in ophthalmology and microsurgery, providing high-precision, easy-to-operate, and digital solutions for clinical surgeries and life sciences [3] - Dishi Medical is positioned to play a significant role in the future of intelligent robotics, which is expected to revolutionize various fields, including healthcare, agriculture, and industry [3]
超显微手术机器人研发商迪视医疗完成近亿元A轮融资,磐霖资本领投